Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2019

Mini Oral session - Gastrointestinal tumours

Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial

Date

23 Nov 2019

Session

Mini Oral session - Gastrointestinal tumours

Topics

Tumour Site

Pancreatic Adenocarcinoma

Presenters

Do-Youn Oh

Citation

Annals of Oncology (2019) 30 (suppl_9): ix42-ix67. 10.1093/annonc/mdz422

Authors

D. Oh1, T. Golan2, P. Hammel3, M. Reni4, E. Van Cutsem5, T. Macarulla6, M.J. Hall7, J. Oh Park8, D. Hochhauser9, D. Arnold10, A. Reinacher-Schick11, G. Tortora12, H. Algül13, E.M. O'Reilly14, D. McGuinness15, K.Y. Cui16, K. Schlienger17, G.Y. Locker16, H.L. Kindler18

Author affiliations

  • 1 -, Seoul National University Hospital, - - Seoul/KR
  • 2 -, The Oncology Institute, Sheba Medical Center at Tel HaShomer, Tel Aviv University, Tel Aviv/IL
  • 3 -, Hôpital Beaujon (AP-­HP), Clichy and University Paris VII, Paris/FR
  • 4 -, IRCCS Ospedale, San Raffaele Scientific Institute, Milan/IT
  • 5 -, University Hospitals Gasthuisberg and KU Leuven, Leuven/BE
  • 6 -, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology, Barcelona/ES
  • 7 -, Fox Chase Cancer Center, Philadelphia/US
  • 8 -, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul/KR
  • 9 -, University College London Cancer Institute, London/GB
  • 10 -, Asklepios Tumorzentrum Hamburg AK Altona, Hamburg/DE
  • 11 -, St Josef-Hospital, Ruhr University Bochum, Bochum/DE
  • 12 -, Azienda Ospedaliera Universitaria Integrata Verona, Verona/IT
  • 13 -, Klinikum rechts der Isar, Department of Internal Medicine II, Technische Universität München, Munich/DE
  • 14 -, Memorial Sloan Kettering Cancer Center, New York/US
  • 15 -, AstraZeneca, Cambridge/GB
  • 16 -, AstraZeneca, Gaithersburg/US
  • 17 -, Merck & Co, Inc., Kenilworth/US
  • 18 -, The University of Chicago, Chicago/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.